“Boston Scientific Neuromodulation Corp. didn’t provide enough evidence that one of its patents covering spinal cord stimulation systems to treat chronic pain was valid, the Federal Circuit ruled.

The U.S. Court of Appeals for the Federal Circuit rejected Boston Scientific’s arguments that its U.S. Patent No. 6,381,496 isn’t invalid for obviousness, according to a nonprecedential opinion.”

Sterne, Kessler, Goldstein & Fox’s representation of Nevro Corp. was mentioned in the article “Boston Scientific Chronic Pain Patent Nixed by Federal Circuit,” published by Bloomberg Law. The team was led by Director Jon E. Wright and included Counsel Richard A. Crudo and Associate Naveed S. Hasan.

© 2022 The Bureau of National Affairs, Inc. All Rights Reserved

Related Professionals

Related Services